InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Organogenesis Holdings Inc.

ORGO Clue Score57
United States Fiscal year ends December CIK 0001661181
$1.29 +0.78% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.29 −89.29% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 5 Jan 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue138.7Operating income−8.8Net income−17.0Fiscal year 2017Revenue198.5 +43.1%Operating income−5.5Net income−8.4Fiscal year 2018Revenue193.4 −2.5%Operating income−51.6Net income−64.8EPS, diluted−0.94Fiscal year 2019Revenue261.0 +34.9%Operating income−29.9Net income−38.7EPS, diluted−0.42Fiscal year 2020Revenue338.3 +29.6%Operating income26.7Net income17.2EPS, diluted0.15Fiscal year 2021Revenue467.4 +38.2%Operating income72.2Net income94.2 +446.6%EPS, diluted0.70 +366.7%Fiscal year 2022Revenue450.9 −3.5%Operating income22.3Net income15.5 −83.5%EPS, diluted0.12 −82.9%Fiscal year 2023Revenue433.1 −3.9%Operating income12.5Net income4.9 −68.2%EPS, diluted0.04 −66.7%Fiscal year 2024Revenue482.0 +11.3%Operating income−1.3Net income0.9 −82.6%EPS, diluted−0.01 −125.0%Fiscal year 2025Revenue564.2 +17.0%Operating income44.7Net income37.0 +4,201.0%EPS, diluted0.15
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 138.7 198.5 193.4 261.0 338.3 467.4 450.9 433.1 482.0 564.2
Growth +43.1% −2.5% +34.9% +29.6% +38.2% −3.5% −3.9% +11.3% +17.0%
Operating income −8.8 −5.5 −51.6 −29.9 26.7 72.2 22.3 12.5 −1.3 44.7
Net income −17.0 −8.4 −64.8 −38.7 17.2 94.2 15.5 4.9 0.9 37.0
Growth +446.6% −83.5% −68.2% −82.6% +4,201.0%
EPS, diluted n/a n/a −0.94 −0.42 0.15 0.70 0.12 0.04 −0.01 0.15
Growth +366.7% −82.9% −66.7% −125.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin65.3%Operating margin−6.3%Net margin−12.2%Free cash flow margin−4.5%Fiscal year 2017Gross margin69.2%Operating margin−2.8%Net margin−4.2%Free cash flow margin−3.0%Fiscal year 2018Gross margin64.4%Operating margin−26.7%Net margin−33.5%Free cash flow margin−32.3%Fiscal year 2019Gross margin70.9%Operating margin−11.4%Net margin−14.8%Free cash flow margin−15.1%Fiscal year 2020Gross margin74.2%Operating margin7.9%Net margin5.1%Free cash flow margin−3.6%Fiscal year 2021Gross margin75.6%Operating margin15.5%Net margin20.2%Free cash flow margin6.6%Fiscal year 2022Gross margin76.7%Operating margin4.9%Net margin3.4%Free cash flow margin−2.0%Fiscal year 2023Gross margin75.4%Operating margin2.9%Net margin1.1%Free cash flow margin1.5%Fiscal year 2024Gross margin76.0%Operating margin−0.3%Net margin0.2%Free cash flow margin0.9%Fiscal year 2025Operating margin7.9%Net margin6.6%Free cash flow margin−4.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 65.3% 69.2% 64.4% 70.9% 74.2% 75.6% 76.7% 75.4% 76.0% n/a
Operating margin −6.3% −2.8% −26.7% −11.4% 7.9% 15.5% 4.9% 2.9% −0.3% 7.9%
Net margin −12.2% −4.2% −33.5% −14.8% 5.1% 20.2% 3.4% 1.1% 0.2% 6.6%
Free cash flow margin −4.5% −3.0% −32.3% −15.1% −3.6% 6.6% −2.0% 1.5% 0.9% −4.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−4.9Capital expenditure−1.4Free cash flow−6.2Fiscal year 2017Operating cash flow−3.5Capital expenditure−2.4Free cash flow−5.9Fiscal year 2018Operating cash flow−60.6Capital expenditure−1.9Free cash flow−62.5Fiscal year 2019Operating cash flow−33.5Capital expenditure−6.0Free cash flow−39.5Fiscal year 2020Operating cash flow5.5Capital expenditure−17.7Free cash flow−12.2Fiscal year 2021Operating cash flow62.0Capital expenditure−31.2Free cash flow30.8Fiscal year 2022Operating cash flow24.9Capital expenditure−33.9Free cash flow−9.0 −129.4%Buybacks0.0Fiscal year 2023Operating cash flow30.9Capital expenditure−24.4Free cash flow6.6Buybacks0.0Fiscal year 2024Operating cash flow14.2Capital expenditure−10.0Free cash flow4.2 −36.3%Buybacks−25.5Fiscal year 2025Operating cash flow−10.3Capital expenditure−14.2Free cash flow−24.5 −685.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −4.9 −3.5 −60.6 −33.5 5.5 62.0 24.9 30.9 14.2 −10.3
Capital expenditure −1.4 −2.4 −1.9 −6.0 −17.7 −31.2 −33.9 −24.4 −10.0 −14.2
Free cash flow −6.2 −5.9 −62.5 −39.5 −12.2 30.8 −9.0 6.6 4.2 −24.5
Growth −129.4% −36.3% −685.7%
Buybacks n/a n/a n/a n/a n/a n/a 0.0 0.0 −25.5 n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash1.9Shareholders’ equity−16.0Fiscal year 2017Cash2.4Total debt52.1Net cash (debt)−49.8Shareholders’ equity−15.3Fiscal year 2018Cash21.4Shareholders’ equity39.9Fiscal year 2019Cash60.4Total debt49.6Net cash (debt)10.7Shareholders’ equity52.0Debt to equity0.95Fiscal year 2020Cash84.4Total debt70.0Net cash (debt)14.4Shareholders’ equity141.8Debt to equity0.49Fiscal year 2021Cash113.9Total debt74.1Net cash (debt)39.9Shareholders’ equity241.3Debt to equity0.31Fiscal year 2022Cash102.5Total debt71.3Net cash (debt)31.2Shareholders’ equity265.7Debt to equity0.27Fiscal year 2023Cash103.8Total debt66.6Net cash (debt)37.3Shareholders’ equity278.7Debt to equity0.24Fiscal year 2024Cash135.6Shareholders’ equity262.9Fiscal year 2025Cash93.7Shareholders’ equity300.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 1.9 2.4 21.4 60.4 84.4 113.9 102.5 103.8 135.6 93.7
Total debt n/a 52.1 n/a 49.6 70.0 74.1 71.3 66.6 n/a n/a
Net cash (debt) n/a −49.8 n/a 10.7 14.4 39.9 31.2 37.3 n/a n/a
Shareholders’ equity −16.0 −15.3 39.9 52.0 141.8 241.3 265.7 278.7 262.9 300.1
Debt to equity n/a n/a n/a 0.95 0.49 0.31 0.27 0.24 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−4.9 −3.5 −60.6 −33.5 5.5 62.0 24.9 30.9 14.2 −10.3
Growth +1,033.9% −59.9% +24.4% −54.0% −172.6%
n/a n/a n/a n/a n/a n/a 5.8 10.4 13.6 15.3
Investment
−1.4 −2.4 −1.9 −6.0 −17.7 −31.2 −33.9 −24.4 −10.0 −14.2
calc −6.2 −5.9 −62.5 −39.5 −12.2 30.8 −9.0 6.6 4.2 −24.5
Growth −129.4% −36.3% −685.7%
calc n/a n/a −0.90 −0.43 −0.11 0.23 −0.07 0.05 0.03 −0.19
−1.2 −14.9 −1.9 −6.2 −23.5 −31.2 −33.9 −24.4 −10.0 −14.2
Financing
6.8 18.9 81.5 78.7 42.5 −1.0 −2.2 −5.5 27.6 −17.4
n/a n/a n/a n/a n/a n/a 0.0 0.0 −25.5 n/a

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.